Medicinal Products

Dáil Éireann Debate, Tuesday - 8 July 2025

• Debates
• Find a debate
  • Dáil debates
  • Seanad debates
  • Committee debates
• Find a vote
  • Dáil votes
  • Seanad votes
  • Committee votes
• Parliamentary questions
  • Written questions
  • Oral questions
• Search tips
• Utterances having an adverse effect

Tuesday, 8 July 2025

Questions (846)

Paul Murphy

Question:

846. Deputy Paul Murphy asked the Minister for Health if her attention has been drawn to the case of a person (details supplied); and if she will instruct their Department to make oral immunotherapy as well as medicines such as omalizumab more widely available, to ensure situations like this do not happen again.; and if she will make a statement on the matter. [37593/25]

Written answers

Minister for Health (Deputy Jennifer Carroll MacNeill)

As this is a service matter and under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices these matters have been referred to the HSE for attention and direct reply to the Deputy.

• Previous Answer
• Next Answer